Manufacturing


  • Image attribution tooltip
    John Moore via Getty Images

    A potential COVID-19 EUA could turn this small biotech into a household name

    Veru’s CEO discusses the impact of the upcoming FDA decision on its treatment targeting severely ill COVID-19 patients.

    By May 19, 2022
  • Image attribution tooltip
    Natali_Mis via Getty Images
    Q&A

    Biotech Spotlight: Graphite Bio seeks sickle cell cure with a next-gen approach

    Using gene editing, CEO Josh Lehrer says the company is poised to ‘offer a cure’ to a long list of diseases.

    By May 17, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Q&A

    Biotech Spotlight: Everest Medicines takes aim at unmet needs in Asia

    With a multi-pronged business strategy, Everest Medicines is positioning itself as a ‘rising force’ in Asian biotech.

    By May 9, 2022
  • Image attribution tooltip

    Adobe Stock / Song about summer

    Sponsored by EVERSANA

    Right-sizing the channel strategy for maximum impact

    Failure to right-size your distribution model imposes financial penalties and wasted expenditures.

    May 9, 2022
  • Image attribution tooltip
    iStock via Getty Images
    Profile

    Breaking new ground: Longhorn's trailblazing effort to develop a universal flu vaccine

    After years of success with their diagnostic platform for COVID-19, tuberculosis and the flu, the family funded company is shifting priorities back to the vaccine market.

    By , May 4, 2022
  • Image attribution tooltip
    Stock via Getty Images

    From the fringes to the forefront — the mRNA era has taken hold of pharma

    A look at what’s next for the industry’s buzziest technology.

    By Kim Ribbink • April 22, 2022
  • Image attribution tooltip
    Andrey Bukreev via Getty Images

    A pharma mystery: Cancer-causing impurities drive joint search for answers

    Pharmaceutical industry insiders and regulators are striving to overcome the ‘blind spots’ that contribute to nitrosamine contamination.

    By April 19, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: iSpecimen's Jill Mullan

    Need biospecimens? iSpecimen aims to be the Amazon of research materials, and Jill Mullan is changing the game.

    By April 13, 2022
  • Image attribution tooltip
    Stock via Getty Images

    Civica Rx thinks it has a cure for high insulin prices

    Civica’s president and CEO, Martin VanTrieste, explains the nonprofit’s aim to manufacture low-cost insulin — and which area of pharma it plans to target next.

    By Kelly Bilodeau • March 16, 2022
  • Image attribution tooltip

    Novartis' manufacturing facility for innovative cell and gene therapies in Stein, Switzerland. Permission granted by Novartis.

    Q&A

    How Novartis kept its supply chain intact during COVID-19

    In an agile pivot, Amit Nastik led Novartis’ manufacturing operations through the pandemic without losing supply chain reliability. 

    By March 16, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Ceek Women's Health CEO Fahti Khosrowshahi

    Fahti Khosrowshahi, CEO and founder, Ceek Women’s Health, is designing award-winning products to change the face of women's health. 

    By March 16, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Lyndra Therapeutics' CEO Dr. Trish Hurter

    With Lyndra's ultra-long-acting therapies, Hurter and the company are aiming to reinvent medicines.

    By March 2, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Opinion

    Industry executives on the milestone moments shaping pharma's future

    Scientific, technological, and communication changes that are making a permanent impact on the industry.

    By Feb. 9, 2022
  • Image attribution tooltip

    Permission granted by Mike Rea.

    Q&A

    Innovation vs. invention

    IDEA Pharma’s indices ranks how well companies turn ideas into commercialized pharma products.

    By Feb. 9, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice

    Welcome to the new PharmaVoice

    A similar mission, a new format, and our plans for PharmaVoice's next chapter.

    By Davide Savenije • Jan. 13, 2022
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Upfront

    GTO and Honeycomb Team Up to Raise Money for Rare Disease The Greater Than One Group (GTO) and its non-profit subsidiary Honeycomb Health conducted a cross-country road trip to raise money for the rare disease cause. In August, Rebecca Trahan began her trip to raise money for Honeycomb Health, a ...

    By PharmaVoice Team • Sept. 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Upfront

    Astellas Oncology Fifth Annual C3 Prize Winners Astellas Oncology has named the winners of its 5th Annual C3 Prize(Changing Cancer Care), a global challenge that sparks cancer care innovations beyond medicine to advance ideas that make a big impact in the cancer community. The program awards up t...

    By PharmaVoice Team • April 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    HealthTech

    Robots Measure Vitals to Minimize Interactions with COVID Patients Trend Watch: COVID-19 Forces Healthtech Innovations from Robots to Partnerships Researchers at Simon Fraser University in Canada have developed three different robots that can sense and measure patients’ healthcare parameters, inc...

    By PharmaVoice Team • April 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Letter from the Editor

    Thank you… Our special Patient Voice issue is one of my favorite issues of the year. Now in its fourth year, this is our opportunity to shine a light on the people who are truly making a difference to the healthcare system. It’s their unwavering pursuit to change the status quo and improve the de...

    By Taren Grom • March 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Letter from the Editor

    Lighting the way… As we say good riddance to 2020, and look toward a more optimistic 2021, we are starting to see some glimmers of light and a more hopeful future. Granted, as they say, hope is not a strategy, but there is hope. At this moment, two COVID-19 vaccines have been approved and million...

    By Taren Grom • Jan. 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    2020 Red Jacket Honorees

    Inspiring Leaders for Today and Tomorrow Since launching the Red Jacket Award in 2014, PharmaVOICE has recognized 40 inspiring, innovative, collaborative, and transformative individuals who epitomize leadership for today and tomorrow. Red Jacket honorees have raised the bar in terms of what it me...

    By PharmaVoice Team • Aug. 1, 2020
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    The Year Ahead…

    We ask more than 130 experts, what needs to happen to address inefficiency and productivity to achieve aspirational goals for healthcare in the future. For this year’s special 2020 Year in Preview issue, we posed 20 provocative questions to our community of thought leaders, who represent all aspe...

    By Taren Grom • Nov. 19, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    2019 Red Jacket Honorees

    Leaders for today and tomorrow PharmaVOICE introduced the Red Jacket Award, now in its fifth year, to celebrate the 10th anniversary of the PharmaVOICE 100. One of the criteria for being named a Red Jacket — our version of a Hall of Fame — is having been recognized previously as a PharmaVOICE 100...

    By PharmaVoice Team • Aug. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Executive Perspective

    Transforming the Lives of Patients: A Conversation with Ron Menezes When Ron Menezes, President and General Manager of Almirall, LLC, took the helm of the U.S. market for the global, Spanish-based company, his mission was clear: become a leader in innovation in the dermatology market. The company...

    By Ron Menezes • June 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Commanders & Chiefs

    Dr. Vas Narasimhan For His Vision to Impact Global Health Title: CEO Company: Novartis Education: BA, Biology, University of Chicago; MPP, Harvard’s John F. Kennedy School of Government; MD, Harvard Medical School Social Media: Tweet: @VasNarasimhan As the new CEO of Novartis, Vas Narasimhan, M.D...

    By PharmaVoice Team • Aug. 1, 2018